<?xml version="1.0" encoding="utf-8"?>
<Spec id="610" path="\3\9\39b7033e54cbc3530285c9a1b556cc0a.pdf"><Text id="89048" page="3">Req. ID Requirement Type GEN-001 M The equipment shall be a co-rotating, fully intermeshing twin-screw extruder designed and validated for pharmaceutical processing. GEN-002 M The nominal screw diameter shall be 11 mm, providing throughput coverage of 1.5 to 3.0 kg/h for typical pharmaceutical polymer/API blends. GEN-003 M The equipment shall have a modular screw and barrel design with geometric equivalence to larger production-scale extruders to enable direct scale-up without reformulation. GEN-004 M The barrel shall consist of a minimum of 6 independently controlled, individually removable heating/cooling zones. GEN-005 M The L/D ratio shall be ≥ 40:1 to ensure adequate residence time for ASD processing. GEN-006 M All product-contact surfaces shall be manufactured from pharmaceutical- grade corrosion-resistant materials (316L stainless steel or equivalent high- alloy tool steel). Surface roughness Ra ≤ 0.8 µm. GEN-007 M Barrel segments shall be horizontally split (clamshell design) or modular bolted for ease of opening, inspection, screw removal, and manual cleaning without major disassembly. GEN-008 M The equipment shall be CE marked and comply with the EU Machinery Directive 2006/42/EC. GEN-009 M The vendor shall demonstrate a documented installed base of equivalent equipment in GMP-regulated pharmaceutical facilities. GEN-010 D Equipment footprint shall be compatible with a standard pharmaceutical development laboratory (floor-standing, max 2.0 m width × 1.5 m depth).</Text><Text id="89085" page="2">This User Requirements Specification (URS) defines the functional, technical, regulatory, safety, and qualification requirements for the procurement of a Hot Melt Extruder (HME) at Research &amp; Development scale (Scope A). The equipment is intended to support pharmaceutical formulation development activities, specifically:</Text></Spec>